Negro-Vilar, MD, PhD, Andres, United States

• Journal of Opioid Management Vol. 2 No. 3 (2006): May/June - Articles
  The ACTION study: A randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA®) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin®) for the treatment of chronic, moderate to severe low back pain
  Abstract  PDF
• Journal of Opioid Management Vol. 2 No. 6 (2006): November/December - Articles
  A randomized, open-label study of once-a-day AVINZA® (morphine sulfate extended-release capsules) versus twice-a-day OxyContin® (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: The extension phase of the ACTION trial
  Abstract  PDF
• Journal of Opioid Management Vol. 3 No. 1 (2007): January/February - Articles
  A randomized, open-label, multicenter trial comparing once-a-day AVINZA® (morphine sulfate extended-release capsules) versus twice-a-day OxyContin® (oxycodone hydrochloride controlled-release tablets) for the treatment of chronic, moderate to severe low back pain: Improved physical functioning in the ACTION trial
  Abstract  PDF
• Journal of Opioid Management Vol. 3 No. 3 (2007): May/June - Articles
  Sleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA®): Findings from a pilot study
  Abstract  PDF